article thumbnail

Is a lack of real-time data holding trials back?

pharmaphorum

Their findings, published in the September 2018 research report Challenges and Opportunities in Clinical Data Management, underscore the severity of the problem. Delayed data delivery. Study data is typically collected by internal and external partners. Potentially catastrophic setbacks. That’s transformative.

article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map.